Company profile: Amunix
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and development, discovering, designing, and developing novel biologics, protein, and peptide therapeutics, with a focus on prodrugs that enable potent immune-activating biotherapeutics for patients with solid tumor cancers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Amunix
Triveni Bio
HQ: United States
Website
- Description: Provider of genetically informed functional antibody therapeutics for immunological and inflammatory disorders, supported by a proprietary data platform that leverages public and private datasets to identify therapeutic targets, predict patient subpopulations, and provide disease insights; lead program TRIV-509 targets kallikreins 5 and 7 for atopic dermatitis and other barrier disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triveni Bio company profile →
Talaris Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology engaged in developing innovative cellular therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Talaris Therapeutics company profile →
Allergopharma
HQ: Germany
Website
- Description: Provider of allergen-specific immunotherapy for type 1 allergies such as hay fever and allergic asthma, offering Allergen Immunotherapy (AIT) to induce immunological tolerance, reduce symptoms, and prevent the progression of allergic diseases, along with diagnostics for IgE-mediated allergies to identify triggers for targeted treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allergopharma company profile →
Graviton
HQ: United States
Website
- Description: Provider of clinical-stage biotech therapies, developing selective ROCK2 inhibitors for fibrotic, autoimmune and CNS diseases; a C6 monoclonal antibody for neurodegenerative diseases; and DYRK inhibitors for diabetes, neurological disorders and cancers. Conducts clinical trials and partners with Ovid Therapeutics and Sino Biopharmaceutical for development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Graviton company profile →
Ampio Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies targeting inflammatory conditions, including OA-201, a small molecule formulation explored as a potential treatment for osteoarthritis of the knee and other joints.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampio Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Amunix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Amunix
2.2 - Growth funds investing in similar companies to Amunix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Amunix
4.2 - Public trading comparable groups for Amunix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →